11.21.19
Berry Global's net sales increase of $965 million from the prior year quarter was primarily attributed to acquisition net sales of $1.2 billion partially offset by decreased selling prices due to the contractual pass through of lower resin costs of $156 million, and lower base volumes of 2%. The quarter included continued volume growth in our Consumer Packaging-North America segment offset by lower base volumes in both of its Health, Hygiene & Specialties and Engineered Materials segments with both improving sequentially, as expected.
The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to lower selling prices of $40 million due to the pass through of lower resin costs, a 2% decline as the result of a customer product transition, a 3% base volume decline as a result of weakness in the North American baby care market, prior year sales of $20 million related to the divested SFL business and a $46 million unfavorable impact from foreign currency changes. These declines were partially offset by acquisition net sales of $164 million related to the Clopay acquisition.
The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to lower selling prices of $40 million due to the pass through of lower resin costs, a 2% decline as the result of a customer product transition, a 3% base volume decline as a result of weakness in the North American baby care market, prior year sales of $20 million related to the divested SFL business and a $46 million unfavorable impact from foreign currency changes. These declines were partially offset by acquisition net sales of $164 million related to the Clopay acquisition.
